Exane Derivatives’s Covanta Holding Corporation CVA Stock Holding History

Exane Derivatives’s Portfolio CVA Stock Details CVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-12,384	Closed	-$249K	–	1120
2021 Q3	$249K	Buy	12,384 +1,792	+17%	+$35.4K	0.06%	340
2021 Q2	$197K	Buy	+10,592	New	+$161K	0.04%	399

Other funds holding CVA

SAM

Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return

Exane Derivatives's CVA Position: Q4 2021 in Review

Exane Derivatives sold out of Covanta Holding Corporation (CVA) in Q4 2021, closing a stake of 12,384 shares — an estimated $249K sold.

Exane Derivatives first reported a position in CVA in Q2 2021 and held it in 2 quarters. The position peaked at $249K in Q3 2021. 2 funds tracked by Wall St. Rank hold CVA as of Q4 2021.

Exane Derivatives reported no remaining Covanta Holding Corporation position as of Q4 2021 after selling out during the quarter.
Exane Derivatives sold 12,384 Covanta Holding Corporation shares in Q4 2021, an estimated $249K.
Exane Derivatives first reported a position in Covanta Holding Corporation in Q2 2021 and held it in 2 quarters.
Exane Derivatives's Covanta Holding Corporation position peaked at $249K in Q3 2021.
2 funds tracked by Wall St. Rank held Covanta Holding Corporation as of Q4 2021.

Based on Exane Derivatives's 13F filing for Q4 2021, filed 28 Jan 2022.